Exozymes Ratios (2023-2024) | EXOZ

Ratios Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024
Profitability
EBT Margin (Quarter) 150,899.57%3,709.93%
EBIT Margin (Quarter) -55,998.57%3,609.93%
EBITDA Margin (Quarter) -55,998.57%3,609.93%
Operating Margin (Quarter) -55,998.57%3,609.93%
Net Margin (Quarter) 150,899.57%3,709.93%
FCF Margin (Quarter) 127,574.71%1,212.90%
Efficiency
Equity Average (Quarter) 0.11M-0.82M-1.76M-2.93M
Invested Capital (Quarter) 0.61M-0.38M-1.25M-2.26M-3.60M
Leverage & Solvency
Interest Coverage Ratio (Quarter) -36.10
Equity Ratio (Quarter) -0.11-1.01
Times Interest Earned (Quarter) -36.10
Valuation
Enterprise Value (Quarter) -0.07M-0.23M
Return Ratios
Return on Sales (Quarter) 1,509.00%5,636.97%37.10%131.33%
Return on Equity (Quarter) 2.25%1.73%